Science news from the best sources

Will the FDA change how it vets treatments following the Alzheimer’s drug debacle?

Max Kozlov

Nature, Published online: 13 May 2022; doi:10.1038/d41586-022-01316-8

The accelerated approval of aducanumab has triggered US lawmakers to push for more oversight from the agency. Read More Nature – Issue – science feeds

Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.